Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement

Giovanna Mantovani, Murat Bastepe, David Monk, Luisa de Sanctis, Susanne Thiele, Alessia Usardi, S. Faisal Ahmed, Roberto Bufo, Timothée Choplin, Gianpaolo de Filippo, Guillemette Devernois, Thomas Eggermann, Francesca M. Elli, Kathleen Freson, Aurora García Ramirez, Emily L. Germain-Lee, Lionel Groussin, Neveen Hamdy, Patrick Hanna, Olaf HiortHarald Jüppner, Peter Kamenický, Nina Knight, Marie Laure Kottler, Elvire Le Norcy, Beatriz Lecumberri, Michael A. Levine, Outi Mäkitie, Regina Martin, Gabriel Ángel Martos-Moreno, Masanori Minagawa, Philip Murray, Arrate Pereda, Robert Pignolo, Lars Rejnmark, Rebecca Rodado, Anya Rothenbuhler, Vrinda Saraff, Ashley H. Shoemaker, Eileen M. Shore, Caroline Silve, Serap Turan, Philip Woods, M. Carola Zillikens, Guiomar Perez de Nanclares, Agnès Linglart

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) and related disorders, which comprise metabolic disorders characterized by physical findings that variably include short bones, short stature, a stocky build, early-onset obesity and ectopic ossifications, as well as endocrine defects that often include resistance to parathyroid hormone (PTH) and TSH. The presentation and severity of PHP and its related disorders vary between affected individuals with considerable clinical and molecular overlap between the different types. A specific diagnosis is often delayed owing to lack of recognition of the syndrome and associated features. The participants in this Consensus Statement agreed that the diagnosis of PHP should be based on major criteria, including resistance to PTH, ectopic ossifications, brachydactyly and early-onset obesity. The clinical and laboratory diagnosis should be confirmed by a molecular genetic analysis. Patients should be screened at diagnosis and during follow-up for specific features, such as PTH resistance, TSH resistance, growth hormone deficiency, hypogonadism, skeletal deformities, oral health, weight gain, glucose intolerance or type 2 diabetes mellitus, and hypertension, as well as subcutaneous and/or deeper ectopic ossifications and neurocognitive impairment. Overall, a coordinated and multidisciplinary approach from infancy through adulthood, including a transition programme, should help us to improve the care of patients affected by these disorders.

Original languageEnglish
Pages (from-to)476-500
Number of pages25
JournalNature Reviews Endocrinology
Volume14
Issue number8
DOIs
Publication statusPublished - 2018

Fingerprint

Pseudohypoparathyroidism
Heterotopic Ossification
Parathyroid Hormone
Obesity
Brachydactyly
Glucose Intolerance
Hypogonadism
Clinical Laboratory Techniques
Oral Health
Type 2 Diabetes Mellitus
Growth Hormone
Weight Gain
Molecular Biology
Patient Care
Hypertension
Bone and Bones

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Diagnosis and management of pseudohypoparathyroidism and related disorders : first international Consensus Statement. / Mantovani, Giovanna; Bastepe, Murat; Monk, David; de Sanctis, Luisa; Thiele, Susanne; Usardi, Alessia; Ahmed, S. Faisal; Bufo, Roberto; Choplin, Timothée; de Filippo, Gianpaolo; Devernois, Guillemette; Eggermann, Thomas; Elli, Francesca M.; Freson, Kathleen; García Ramirez, Aurora; Germain-Lee, Emily L.; Groussin, Lionel; Hamdy, Neveen; Hanna, Patrick; Hiort, Olaf; Jüppner, Harald; Kamenický, Peter; Knight, Nina; Kottler, Marie Laure; Le Norcy, Elvire; Lecumberri, Beatriz; Levine, Michael A.; Mäkitie, Outi; Martin, Regina; Martos-Moreno, Gabriel Ángel; Minagawa, Masanori; Murray, Philip; Pereda, Arrate; Pignolo, Robert; Rejnmark, Lars; Rodado, Rebecca; Rothenbuhler, Anya; Saraff, Vrinda; Shoemaker, Ashley H.; Shore, Eileen M.; Silve, Caroline; Turan, Serap; Woods, Philip; Zillikens, M. Carola; Perez de Nanclares, Guiomar; Linglart, Agnès.

In: Nature Reviews Endocrinology, Vol. 14, No. 8, 2018, p. 476-500.

Research output: Contribution to journalArticle

Mantovani, G, Bastepe, M, Monk, D, de Sanctis, L, Thiele, S, Usardi, A, Ahmed, SF, Bufo, R, Choplin, T, de Filippo, G, Devernois, G, Eggermann, T, Elli, FM, Freson, K, García Ramirez, A, Germain-Lee, EL, Groussin, L, Hamdy, N, Hanna, P, Hiort, O, Jüppner, H, Kamenický, P, Knight, N, Kottler, ML, Le Norcy, E, Lecumberri, B, Levine, MA, Mäkitie, O, Martin, R, Martos-Moreno, GÁ, Minagawa, M, Murray, P, Pereda, A, Pignolo, R, Rejnmark, L, Rodado, R, Rothenbuhler, A, Saraff, V, Shoemaker, AH, Shore, EM, Silve, C, Turan, S, Woods, P, Zillikens, MC, Perez de Nanclares, G & Linglart, A 2018, 'Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement', Nature Reviews Endocrinology, vol. 14, no. 8, pp. 476-500. https://doi.org/10.1038/s41574-018-0042-0
Mantovani, Giovanna ; Bastepe, Murat ; Monk, David ; de Sanctis, Luisa ; Thiele, Susanne ; Usardi, Alessia ; Ahmed, S. Faisal ; Bufo, Roberto ; Choplin, Timothée ; de Filippo, Gianpaolo ; Devernois, Guillemette ; Eggermann, Thomas ; Elli, Francesca M. ; Freson, Kathleen ; García Ramirez, Aurora ; Germain-Lee, Emily L. ; Groussin, Lionel ; Hamdy, Neveen ; Hanna, Patrick ; Hiort, Olaf ; Jüppner, Harald ; Kamenický, Peter ; Knight, Nina ; Kottler, Marie Laure ; Le Norcy, Elvire ; Lecumberri, Beatriz ; Levine, Michael A. ; Mäkitie, Outi ; Martin, Regina ; Martos-Moreno, Gabriel Ángel ; Minagawa, Masanori ; Murray, Philip ; Pereda, Arrate ; Pignolo, Robert ; Rejnmark, Lars ; Rodado, Rebecca ; Rothenbuhler, Anya ; Saraff, Vrinda ; Shoemaker, Ashley H. ; Shore, Eileen M. ; Silve, Caroline ; Turan, Serap ; Woods, Philip ; Zillikens, M. Carola ; Perez de Nanclares, Guiomar ; Linglart, Agnès. / Diagnosis and management of pseudohypoparathyroidism and related disorders : first international Consensus Statement. In: Nature Reviews Endocrinology. 2018 ; Vol. 14, No. 8. pp. 476-500.
@article{f70a3592e1444d1297056e8bde8a7899,
title = "Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement",
abstract = "This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) and related disorders, which comprise metabolic disorders characterized by physical findings that variably include short bones, short stature, a stocky build, early-onset obesity and ectopic ossifications, as well as endocrine defects that often include resistance to parathyroid hormone (PTH) and TSH. The presentation and severity of PHP and its related disorders vary between affected individuals with considerable clinical and molecular overlap between the different types. A specific diagnosis is often delayed owing to lack of recognition of the syndrome and associated features. The participants in this Consensus Statement agreed that the diagnosis of PHP should be based on major criteria, including resistance to PTH, ectopic ossifications, brachydactyly and early-onset obesity. The clinical and laboratory diagnosis should be confirmed by a molecular genetic analysis. Patients should be screened at diagnosis and during follow-up for specific features, such as PTH resistance, TSH resistance, growth hormone deficiency, hypogonadism, skeletal deformities, oral health, weight gain, glucose intolerance or type 2 diabetes mellitus, and hypertension, as well as subcutaneous and/or deeper ectopic ossifications and neurocognitive impairment. Overall, a coordinated and multidisciplinary approach from infancy through adulthood, including a transition programme, should help us to improve the care of patients affected by these disorders.",
author = "Giovanna Mantovani and Murat Bastepe and David Monk and {de Sanctis}, Luisa and Susanne Thiele and Alessia Usardi and Ahmed, {S. Faisal} and Roberto Bufo and Timoth{\'e}e Choplin and {de Filippo}, Gianpaolo and Guillemette Devernois and Thomas Eggermann and Elli, {Francesca M.} and Kathleen Freson and {Garc{\'i}a Ramirez}, Aurora and Germain-Lee, {Emily L.} and Lionel Groussin and Neveen Hamdy and Patrick Hanna and Olaf Hiort and Harald J{\"u}ppner and Peter Kamenick{\'y} and Nina Knight and Kottler, {Marie Laure} and {Le Norcy}, Elvire and Beatriz Lecumberri and Levine, {Michael A.} and Outi M{\"a}kitie and Regina Martin and Martos-Moreno, {Gabriel {\'A}ngel} and Masanori Minagawa and Philip Murray and Arrate Pereda and Robert Pignolo and Lars Rejnmark and Rebecca Rodado and Anya Rothenbuhler and Vrinda Saraff and Shoemaker, {Ashley H.} and Shore, {Eileen M.} and Caroline Silve and Serap Turan and Philip Woods and Zillikens, {M. Carola} and {Perez de Nanclares}, Guiomar and Agn{\`e}s Linglart",
year = "2018",
doi = "10.1038/s41574-018-0042-0",
language = "English",
volume = "14",
pages = "476--500",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Diagnosis and management of pseudohypoparathyroidism and related disorders

T2 - first international Consensus Statement

AU - Mantovani, Giovanna

AU - Bastepe, Murat

AU - Monk, David

AU - de Sanctis, Luisa

AU - Thiele, Susanne

AU - Usardi, Alessia

AU - Ahmed, S. Faisal

AU - Bufo, Roberto

AU - Choplin, Timothée

AU - de Filippo, Gianpaolo

AU - Devernois, Guillemette

AU - Eggermann, Thomas

AU - Elli, Francesca M.

AU - Freson, Kathleen

AU - García Ramirez, Aurora

AU - Germain-Lee, Emily L.

AU - Groussin, Lionel

AU - Hamdy, Neveen

AU - Hanna, Patrick

AU - Hiort, Olaf

AU - Jüppner, Harald

AU - Kamenický, Peter

AU - Knight, Nina

AU - Kottler, Marie Laure

AU - Le Norcy, Elvire

AU - Lecumberri, Beatriz

AU - Levine, Michael A.

AU - Mäkitie, Outi

AU - Martin, Regina

AU - Martos-Moreno, Gabriel Ángel

AU - Minagawa, Masanori

AU - Murray, Philip

AU - Pereda, Arrate

AU - Pignolo, Robert

AU - Rejnmark, Lars

AU - Rodado, Rebecca

AU - Rothenbuhler, Anya

AU - Saraff, Vrinda

AU - Shoemaker, Ashley H.

AU - Shore, Eileen M.

AU - Silve, Caroline

AU - Turan, Serap

AU - Woods, Philip

AU - Zillikens, M. Carola

AU - Perez de Nanclares, Guiomar

AU - Linglart, Agnès

PY - 2018

Y1 - 2018

N2 - This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) and related disorders, which comprise metabolic disorders characterized by physical findings that variably include short bones, short stature, a stocky build, early-onset obesity and ectopic ossifications, as well as endocrine defects that often include resistance to parathyroid hormone (PTH) and TSH. The presentation and severity of PHP and its related disorders vary between affected individuals with considerable clinical and molecular overlap between the different types. A specific diagnosis is often delayed owing to lack of recognition of the syndrome and associated features. The participants in this Consensus Statement agreed that the diagnosis of PHP should be based on major criteria, including resistance to PTH, ectopic ossifications, brachydactyly and early-onset obesity. The clinical and laboratory diagnosis should be confirmed by a molecular genetic analysis. Patients should be screened at diagnosis and during follow-up for specific features, such as PTH resistance, TSH resistance, growth hormone deficiency, hypogonadism, skeletal deformities, oral health, weight gain, glucose intolerance or type 2 diabetes mellitus, and hypertension, as well as subcutaneous and/or deeper ectopic ossifications and neurocognitive impairment. Overall, a coordinated and multidisciplinary approach from infancy through adulthood, including a transition programme, should help us to improve the care of patients affected by these disorders.

AB - This Consensus Statement covers recommendations for the diagnosis and management of patients with pseudohypoparathyroidism (PHP) and related disorders, which comprise metabolic disorders characterized by physical findings that variably include short bones, short stature, a stocky build, early-onset obesity and ectopic ossifications, as well as endocrine defects that often include resistance to parathyroid hormone (PTH) and TSH. The presentation and severity of PHP and its related disorders vary between affected individuals with considerable clinical and molecular overlap between the different types. A specific diagnosis is often delayed owing to lack of recognition of the syndrome and associated features. The participants in this Consensus Statement agreed that the diagnosis of PHP should be based on major criteria, including resistance to PTH, ectopic ossifications, brachydactyly and early-onset obesity. The clinical and laboratory diagnosis should be confirmed by a molecular genetic analysis. Patients should be screened at diagnosis and during follow-up for specific features, such as PTH resistance, TSH resistance, growth hormone deficiency, hypogonadism, skeletal deformities, oral health, weight gain, glucose intolerance or type 2 diabetes mellitus, and hypertension, as well as subcutaneous and/or deeper ectopic ossifications and neurocognitive impairment. Overall, a coordinated and multidisciplinary approach from infancy through adulthood, including a transition programme, should help us to improve the care of patients affected by these disorders.

UR - http://www.scopus.com/inward/record.url?scp=85049131329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049131329&partnerID=8YFLogxK

U2 - 10.1038/s41574-018-0042-0

DO - 10.1038/s41574-018-0042-0

M3 - Article

AN - SCOPUS:85049131329

VL - 14

SP - 476

EP - 500

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

SN - 1759-5029

IS - 8

ER -